Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Signal News Directory
  • Pain & Anaesthesia

Pain & Anaesthesia

  • Regulatory

AbbVie receives EC approval for Aquipta to treat migraine

pharminent June 3, 2026
  • Regulatory

VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain

pharminent May 19, 2026
  • Commercial

A year after Vertex’s big launch, pain drug research faces a pivotal moment

pharminent May 12, 2026
  • M&A / Deals

AbbVie enters world of pain in up to $715M deal with China’s Haisco

pharminent April 13, 2026
  • M&A / Deals

AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid

pharminent April 13, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.